Trial intelligence / Profile preview

Effect of hiatal hernia on efficacy of baclofen in GERD

2006-003418-16Phase 2Active

Sponsor
Academic Medical Center
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Baclofen with Placebo (2 arms). Primary endpoint: Rate of acid and non-acid reflux episodes. Started Jul 2006; status: active.

02

Drugs

baclofen
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on 2006-003418-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003418-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call